{"disease":{"id":"mild-to-moderate-alzheimer-s-disease","name":"mild to moderate alzheimer s disease"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03069014","title":"Study of LM11A-31-BHS in Mild-moderate AD Patients","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":242,"lead_sponsor_name":"PharmatrophiX Inc.","has_results":false},{"nct_id":"NCT03625622","title":"Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":210,"lead_sponsor_name":"AriBio Co., Ltd.","has_results":false},{"nct_id":"NCT05189210","title":"GV1001 Subcutaneous(SC) for the Treatment of Mild to Moderate Alzheimer's Disease (AD)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":199,"lead_sponsor_name":"GemVax & Kael","has_results":false},{"nct_id":"NCT03507790","title":"A Study to Evaluate the Safety and Efficacy of CT1812 in Subjects With Mild to Moderate Alzheimer's Disease.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":153,"lead_sponsor_name":"Cognition Therapeutics","has_results":true},{"nct_id":"NCT02703636","title":"NextStep:Study to Evaluate Safety,Efficacy & Tolerability of Rivastigmine Patch in Mild to Moderate Alzheimer's Patients.","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT03462121","title":"A Clinical Study Evaluating the Efficacy and Safety of RPh201 Treatment in Individuals With Alzheimer's Disease With or Without Coexisting Cerebrovascular Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Regenera Pharma Ltd","has_results":false},{"nct_id":"NCT06008639","title":"Efficacy and Safety of Near Infrared Light Therapy for Alzheimer's Disease","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Danyang Huichuang Medical Equipment Co., Ltd.","has_results":false},{"nct_id":"NCT07457125","title":"The Effect of CB-Exo-A600 in Mild to Moderate Alzheimer's Disease","phase":"PHASE1, PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":33,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT03867253","title":"Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Oryzon Genomics S.A.","has_results":false}],"total":9},"guidelines":[],"source":"Drug Landscape verified database"}